Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000244899 | SCV000319499 | likely benign | Cardiovascular phenotype | 2015-04-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000734570 | SCV000862722 | uncertain significance | not provided | 2018-07-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001442516 | SCV001645465 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000734570 | SCV004702685 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | JAG1: BP4, BP7 |